316 related articles for article (PubMed ID: 27566992)
1. Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children.
Zhou W; Johnson TN; Xu H; Cheung S; Bui KH; Li J; Al-Huniti N; Zhou D
CPT Pharmacometrics Syst Pharmacol; 2016 Sep; 5(9):475-83. PubMed ID: 27566992
[TBL] [Abstract][Full Text] [Related]
2. A GFR-Based Method to Predict the Effect of Renal Impairment on the Exposure or Clearance of Renally Excreted Drugs: A Comparative Study Between a Simple GFR Method and a Physiologically Based Pharmacokinetic Model.
Mahmood I
Drugs R D; 2020 Dec; 20(4):377-387. PubMed ID: 33150526
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Clearance in Neonates and Infants (≤ 3 Months of Age) for Drugs That Are Glucuronidated: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling.
Mahmood I; Ahmad T; Mansoor N; Sharib SM
J Clin Pharmacol; 2017 Apr; 57(4):476-483. PubMed ID: 27704554
[TBL] [Abstract][Full Text] [Related]
4. Optimizing pharmacokinetic bridging studies in paediatric oncology using physiologically-based pharmacokinetic modelling: application to docetaxel.
Thai HT; Mazuir F; Cartot-Cotton S; Veyrat-Follet C
Br J Clin Pharmacol; 2015 Sep; 80(3):534-47. PubMed ID: 26095234
[TBL] [Abstract][Full Text] [Related]
5. A simplified PBPK modeling approach for prediction of pharmacokinetics of four primarily renally excreted and CYP3A metabolized compounds during pregnancy.
Xia B; Heimbach T; Gollen R; Nanavati C; He H
AAPS J; 2013 Oct; 15(4):1012-24. PubMed ID: 23835676
[TBL] [Abstract][Full Text] [Related]
6. Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.
Dallmann A; Ince I; Solodenko J; Meyer M; Willmann S; Eissing T; Hempel G
Clin Pharmacokinet; 2017 Dec; 56(12):1525-1541. PubMed ID: 28391404
[TBL] [Abstract][Full Text] [Related]
7. The use of PBPK modeling across the pediatric age range using propofol as a case.
Michelet R; Van Bocxlaer J; Allegaert K; Vermeulen A
J Pharmacokinet Pharmacodyn; 2018 Dec; 45(6):765-785. PubMed ID: 30298439
[TBL] [Abstract][Full Text] [Related]
8. Physiologically Based Pharmacokinetic Prediction of Linezolid and Emtricitabine in Neonates and Infants.
Duan P; Fisher JW; Yoshida K; Zhang L; Burckart GJ; Wang J
Clin Pharmacokinet; 2017 Apr; 56(4):383-394. PubMed ID: 27596256
[TBL] [Abstract][Full Text] [Related]
9. Model qualification of the PK-Sim® pediatric module for pediatric exposure assessment of CYP450 metabolized compounds.
Yun YE; Edginton AN
J Toxicol Environ Health A; 2019; 82(14):789-814. PubMed ID: 31405354
[TBL] [Abstract][Full Text] [Related]
10. PBPK Modeling of the Effect of Reduced Kidney Function on the Pharmacokinetics of Drugs Excreted Renally by Organic Anion Transporters.
Hsueh CH; Hsu V; Zhao P; Zhang L; Giacomini KM; Huang SM
Clin Pharmacol Ther; 2018 Mar; 103(3):485-492. PubMed ID: 28738449
[TBL] [Abstract][Full Text] [Related]
11. Physiologically Based Pharmacokinetic Modeling of Oxycodone in Children to Support Pediatric Dosing Optimization.
Zheng L; Xu M; Tang SW; Song HX; Jiang XH; Wang L
Pharm Res; 2019 Oct; 36(12):171. PubMed ID: 31654287
[TBL] [Abstract][Full Text] [Related]
12. PBPK and its Virtual Populations: the Impact of Physiology on Pediatric Pharmacokinetic Predictions of Tramadol.
T'jollyn H; Vermeulen A; Van Bocxlaer J
AAPS J; 2018 Nov; 21(1):8. PubMed ID: 30498862
[TBL] [Abstract][Full Text] [Related]
13. Physiologically based pharmacokinetic model of renally cleared antibacterial drugs in Chinese renal impairment patients.
Cui C; Li X; Liang H; Hou Z; Tu S; Dong Z; Yao X; Zhang M; Zhang X; Li H; Zuo X; Liu D
Biopharm Drug Dispos; 2021 Jan; 42(1):24-34. PubMed ID: 33340419
[TBL] [Abstract][Full Text] [Related]
14. Renal Clearance in Newborns and Infants: Predictive Performance of Population-Based Modeling for Drug Development.
Wang J; Kumar SS; Sherwin CM; Ward R; Baer G; Burckart GJ; Wang Y; Yao LP
Clin Pharmacol Ther; 2019 Jun; 105(6):1462-1470. PubMed ID: 30565653
[TBL] [Abstract][Full Text] [Related]
15. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.
Johnson TN; Rostami-Hodjegan A
Paediatr Anaesth; 2011 Mar; 21(3):291-301. PubMed ID: 20497354
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetic analysis of rivaroxaban in children and comparison to prospective physiologically-based pharmacokinetic predictions.
Willmann S; Coboeken K; Zhang Y; Mayer H; Ince I; Mesic E; Thelen K; Kubitza D; Lensing AWA; Yang H; Zhu P; Mück W; Drenth HJ; Lippert J
CPT Pharmacometrics Syst Pharmacol; 2021 Oct; 10(10):1195-1207. PubMed ID: 34292671
[TBL] [Abstract][Full Text] [Related]
17. Estimation of Ontogeny Functions for Renal Transporters Using a Combined Population Pharmacokinetic and Physiology-Based Pharmacokinetic Approach: Application to OAT1,3.
Cristea S; Krekels EHJ; Allegaert K; De Paepe P; de Jaeger A; De Cock P; Knibbe CAJ
AAPS J; 2021 May; 23(3):65. PubMed ID: 33948771
[TBL] [Abstract][Full Text] [Related]
18. Predictive Performance of Physiology-Based Pharmacokinetic Dose Estimates for Pediatric Trials: Evaluation With 10 Bayer Small-Molecule Compounds in Children.
Ince I; Dallmann A; Frechen S; Coboeken K; Niederalt C; Wendl T; Block M; Meyer M; Eissing T; Burghaus R; Lippert J; Willmann S; Schlender JF
J Clin Pharmacol; 2021 Jun; 61 Suppl 1(Suppl 1):S70-S82. PubMed ID: 34185905
[TBL] [Abstract][Full Text] [Related]
19. Predictive Pediatric Modeling and Simulation Using Ontogeny Information.
Ince I; Solodenko J; Frechen S; Dallmann A; Niederalt C; Schlender J; Burghaus R; Lippert J; Willmann S
J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S95-S103. PubMed ID: 31502689
[TBL] [Abstract][Full Text] [Related]
20. Incorporating Ontogeny in Physiologically Based Pharmacokinetic Modeling to Improve Pediatric Drug Development: What We Know About Developmental Changes in Membrane Transporters.
Cheung KWK; van Groen BD; Burckart GJ; Zhang L; de Wildt SN; Huang SM
J Clin Pharmacol; 2019 Sep; 59 Suppl 1(Suppl 1):S56-S69. PubMed ID: 31502692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
